ILMN NASDAQ

Illumina

Follow Open structure map Ask about this Research this company

Description

ILMN · NASDAQ

Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function.

Wikipedia · CC BY-SA 4.0

Headquarters: US
Reporting currency: USD
Website: Website

Claims

Read the assertion alongside its sources. Expand a row to inspect the evidence.

FactEvidence 1

tickerILMN

Illumina, Inc. (NASDAQ: ILMN)

PR Newswire news releases · 2026-10-09 04:06

View evidence

CompanyPR Newswire news releases2026-10-09 04:06
Illumina, Inc. (NASDAQ: ILMN)
View source

FactEvidence 1

third quarter 2026 financial results announcement dateOctober 29, 2026

it will issue results for the third quarter 2026 following the close of market on Thursday, October 29, 2026.

PR Newswire news releases · 2026-10-09 04:06

View evidence

CompanyPR Newswire news releases2026-10-09 04:06
it will issue results for the third quarter 2026 following the close of market on Thursday, October 29, 2026.
View source

FactEvidence 1

price target200 $

No public evidence summary is available.

GDELT Global Knowledge Graph · 2026-10-07 21:45

View evidence

MediaGDELT Global Knowledge Graph2026-10-07 21:45
View source

Showing 1 to 3 of 3

Market and valuation

Valuation data is available on Pro and Research.

Included in Pro

Filings

Not available: Company signals · Relations · Financials · Guidance